Main

The epithelial lining fluid of the lung with its high concentration of antioxidants provides a first line of defense against inhaled, but also endogenously produced, oxidants (1, 2). Epidemiologic studies have found an inverse association between ascorbate intake and bronchial hyperresponsivness (3). In a small group of patients with exercise-induced asthma, Cohen et al. (4) showed that supplementation with ascorbate improved lung function. Dietary supplementation with a vitamin combination (ascorbic acid, α-tocopherol, and α-carotene) also had some positive effect on lung function during exercise in combination with ozone exposure (5). Studies in adults living in the United Kingdom have shown that low intake of fresh fruit and vegetables is a risk factor for decreased lung function (6, 7). Changes in ascorbate and urate in the lining fluid of the respiratory tract have been observed as a response to acute air pollution exposure (8) and recently in adults with mild asthma (9). Inflammatory cells from peripheral blood and BAL fluid of asthmatic subjects produce more superoxide anion radicals than those of control subjects (1012). Treatment with corticosteroids has been shown to reduce the amount of oxygen radicals released by these cells (13).

In children, asthma is defined by symptoms such as wheeze or cough (14), and we have recently shown that atopic asthma is a chronic inflammatory disease in children as in adults (15). Ongoing inflammation in the airways of children with atopic asthma may lead to enhanced oxidative stress in the epithelial lining fluid, which may, as a consequence, lead to a higher consumption of the antioxidants found in BAL fluid. Oxidative damage to BAL proteins may reflect overall oxidative stress to the respiratory tract that could contribute to the underlying pathophysiology of established asthma. We have recently reported concentrations of total ascorbate, urate, α-tocopherol, and oxidized proteins in BAL fluid in nonasthmatic children (16). However, there are currently no data available on the antioxidant status in the epithelial lining fluid of asthmatic children. The present study compares the concentrations of those antioxidants and oxidized proteins in BAL fluid of children with stable atopic asthma with our normal values. Additionally, we determined MDA as a marker of lipid peroxidation in BAL fluid and several antioxidants in serum of these children.

METHODS

Subjects.

Otherwise well, stable, atopic asthmatic children attending the Royal Belfast Hospital for Sick Children for elective surgery for a noninflammatory condition were recruited as part of an ongoing research study on childhood asthma. A detailed respiratory and allergy history, which also included information on parental smoking, type of home heating, and serum IgE measurements, was used, as previously described, to categorize the children (17, 18). The children were defined as atopic asthmatics because in addition to recurrent episodes of wheezing they had some or all of the following features:1) other atopy (eczema, hayfever), 2) wheeze triggered by aeroallergen exposure, or 3) an elevated serum IgE (>2 SD from age normal controls) (17). Forty-seven children were reported to take antiinflammatory asthma therapy (43 ICS, four sodium cromoglycate). A further 18 children used bronchodilators only when required. We compared the results from the atopic asthmatic children (n = 78) with a group of 124 control children (nonasthmatic–nonatopic and atopic–nonasthmatic) whom we have previously reported (16). All children (atopic asthmatic and nonasthmatic) were attending elective surgery for a noninflammatory condition, mainly for minor corrective plastic surgery, surgery to the renal tract, and repairs of cleft lips and palate. At the time of the investigation all children were considered to be free from recent upper respiratory tract infections for at least 2 wk. Additionally none of the parents or guardians reported asthma exacerbations experienced by the children at the time of the study, and all were deemed fit for surgery by the anesthetist. Written informed consent was obtained from parents or guardians of each recruited subject before surgery. The study was approved by the Research Ethics Committee of The Queen's University of Belfast.

Bronchoalveolar lavage.

BAL procedure followed our standard protocol for a blind nonbronchoscopic technique (16, 18). Briefly, after the induction of anesthesia and intubation, a sterile 8F graduated neonatal suction catheter was inserted through the endotracheal tube and wedged in a distal airway. Lavage was performed with a single 20-mL aliquot of normal saline, and the lavage fluid was immediately aspirated. A 500-μL aliquot of the sample was incubated with a final concentration of 10 mmol/L Na2EDTA and 35 mmol/L DTT for 30 min on ice and in the dark. After centrifugation (200 ×g, 5 min, 4°C) the supernatant was frozen at −70°C until assayed.

Total cell count and differential cell counts.

Cells in BAL fluid were enumerated as previously described (18). Briefly, after total cell count using a Neubauer chamber, coverslip preparations were prepared and stained with a commercially available stain (DiffQuick, Baxter AG, Düdingen, Switzerland), and a total number of at least 500 cells were counted and differentiated in a blinded fashion. Mast cells were enumerated after fixation in Carnoy's solution and staining with toluidine blue, with 2000–5000 cells counted per coverslip.

Ascorbic acid and uric acid in BAL fluid.

The HPLC method with electrochemical detection described by Chevion et al. (19) was used to determine ascorbate and urate concentrations. Standards of both antioxidants (0.25–2 μmol/L) were prepared in 0.9% sodium chloride with a final concentration of 10 mmol/L Na2EDTA and 35 mmol/L DTT. The detection limits were 0.106 μmol/L for ascorbate and 0.030 μmol/L for urate. The interassay coefficient of variation was 7.8% for ascorbic acid (n = 33) and 9.1% (n = 28) for uric acid.

α-Tocopherol in BAL fluid.

α-Tocopherol was measured by HPLC with electrochemical detection according to the method described by Ikenoya et al. (20). Extraction of α-tocopherol was performed as described by Ito et al. (21). The detection limit was 0.0028 μmol/L (n = 5), and the interassay coefficient of variation was 12.1% (n = 24).

Protein carbonyls in BAL fluid.

Carbonyl concentrations were determined using an in-house ELISA as described by Buss et al. (22). Briefly, after derivatization of carbonyl groups with dinitrophenylhydrazine (DNPH), proteins were adsorbed onto 96-well ELISA plates, captured with a commercially available anti-DNPH antibody, and detected with a horseradish peroxidase–hydrogen peroxide, phenylene diamine system (18). The limit of detection was 0.28 nmol/mg protein.

Total protein.

Total protein concentrations were quantified using the commercially available Bio-Rad assay (Bio-Rad Laboratories Ltd., Hemel Hempstead, U.K.).

MDA assay.

MDA was determined by HPLC with fluorometric detection after reaction with thiobarbituric acid (23). The limit of detection was 0.03 μmol/L.

Antioxidants in serum.

The lipid-soluble vitamins retinol, α-tocopherol, α-carotene, β-carotene, and lycopene were measured by HPLC with UV detection as described by Ito et al. (21). Ascorbate and urate were determined in serum samples after deproteination in 5%m-phosphoric acid (19). The detection limits were 0.11 μmol/L for retinol, 1.2 μmol/L for α-tocopherol, 0.01 μmol/L for carotenoids, 6.2 μmol/L for ascorbate, and 12.3 μmol/L for urate.

Data analyses.

The data were described using mean ± SD or median (interquartile range, IQR) as appropriate. Statistical comparisons were performed using the Mann-Whitney U test. The Spearman's correlation coefficient was used to calculate the association between variables. A probability value of <0.05 was regarded as statistically significant. All statistical analyses were carried out using SPSS (Version 8.0, Chicago, IL, U.S.A.) for Windows and GraphPad Prism (Version 2.01, San Diego, CA, U.S.A.).

RESULTS

Subjects.

A total of 78 atopic, asthmatic children [AA: mean age, 7.2 ± 3.3 y; range, 1.1–13.5 y; 49 boys] were studied. One hundred twenty-four healthy nonasthmatic children of a similar age were used as controls, as previously reported (16) (Table 1).

Table 1 Characteristics of all children studied

The mean volume return was 36.5 ± 12.7% in atopic asthmatic children and 36.8 ± 11.8% in control children (p = 0.99). The total and differential cell counts (mean percentage) are expressed in Table 1. The proportions of eosinophils and mast cells were significantly elevated in BAL fluid of atopic asthmatic children (p < 0.0001 and p = 0.0007, respectively).

Antioxidants and oxidation products in BAL fluid.

The concentrations of total protein [median (IQR)] were similar in atopic asthmatic children and controls (AA: 56.2 (29.9–85.2) μg/mL, and C: 50.2 (31.2–76.2) μg/mL;p = 0.47). Concentrations of antioxidants (ascorbate, urate, and α-tocopherol, in μmol/L), total proteins (in μg/mL), and protein carbonyls (expressed in nmol/mg and pmol/L) for asthmatics and controls are given in Table 2. The concentrations of total ascorbate (Fig. 1), urate (Fig. 2), and α-tocopherol (Fig. 3; all in μmol/L) were similar in asthmatic children compared with the control group (all p > 0.05). When corrected for total protein, median concentrations of total ascorbate and urate (in nmol/mg protein) were lower in atopic asthmatic children compared with controls, but these differences were not statistically significant [ascorbate: 6.473 (5.01–13.17) nmol/mg protein versus 8.720 (5.569–15.41) nmol/mg protein, p = 0.15; urate: 8.796 (6.279–13.48) nmol/mg protein versus 9.578 (7.205–15.63) nmol/mg protein;p = 0.34]. Similar concentrations between the two groups were found when α-tocopherol was corrected for protein concentrations [AA: 0.367 (0.173–0.602) nmol/mg versus C: 0.333 (0.233–0.602) nmol/mg;p = 0.88 for atopic asthmatic and control children, respectively].

Table 2 Concentrations of antioxidants and markers of oxidative stress in BAL fluid
Figure 1
figure 1

Concentrations of total ascorbate (μmol/L) in BAL fluid of children with atopic asthma (). For comparison the concentrations for previously published control children (•) are also plotted (16).

Figure 2
figure 2

Concentrations of urate (μmol/L) in BAL fluid of children with atopic asthma (). For comparison the concentrations for previously published control children (•) are also plotted (16).

Figure 3
figure 3

Concentrations of α-tocopherol (μmol/L) in BAL fluid of children with atopic asthma (). For comparison the concentrations for previously published control children (•) are also plotted (16).

The concentrations of protein carbonyls in BAL fluid (in nmol/mg) were similar in atopic asthmatic children and controls (Fig. 4 and Table 2). Corrected for the BAL volume, atopic asthmatics had a tendency for increased concentrations of protein carbonyls (in pmol/L) compared with controls, but this was not statistically significant [AA: 84.91 (44.13–121.5) pmol/L versus 67.37 (39.48–114.8) pmol/L, p = 0.30]. In a small subgroup of the children, in whom we had adequate volume of lavage fluid, we measured MDA, a marker of lipid peroxidation. BAL fluid concentrations of MDA were also similar in atopic asthmatic children and nonasthmatic controls (Table 2).

Figure 4
figure 4

Protein carbonyl concentrations (nmol/mg protein) in BAL fluid of children with atopic asthma (). For comparison the concentrations for previously published control children (•) are also plotted (16).

Serum antioxidant concentrations.

Serum concentrations of ascorbate, urate, α-tocopherol, retinol, lycopene, and β-carotene were similar in the two groups of children. Children with atopic asthma had statistically significantly reduced serum concentrations of α-carotene (p = 0.048). The concentrations of serum antioxidants are given in Table 3.

Table 3 Water-soluble and lipid-soluble antioxidants in serum

Correlations.

We expressed the concentration of protein carbonyl residues in picomoles per liter to be able to analyze their association with antioxidant concentrations or numbers of inflammatory cells. In atopic asthmatic children the concentration of total protein correlated significantly with concentrations of all antioxidants measured in BAL fluid (ascorbate:r = 0.55, n = 39, p = 0.0003; urate:r = 0.66, n = 40, p < 0.0001; α-tocopherol:r = 0.45, n = 34, p = 0.008;Table 4). Correlations between oxidized proteins and ascorbate or urate were slightly higher for atopic, asthmatic children than nonasthmatic control children. In asthmatic children, the number of inflammatory cells (× 105/mL) in BAL fluid correlated significantly with the concentration of protein carbonyls (all p < 0.05;Table 4). Furthermore, in asthmatic children with BAL eosinophils, which were greater than our previously published upper 95% confidence limit of the 95th centile of our normal population (24) (≥0.86% or ≥0.039 × 105/mL, n = 30), protein carbonyls were significantly higher than in those asthmatic children with normal eosinophil numbers (elevated eosinophils: 107.5 pmol/L versus normal eosinophils: 66.43 pmol/L, p < 0.0028). Thus ongoing airway inflammation is reflected by increased oxidative damage to proteins. Additionally, in control children the numbers of eosinophils, mast cells, and macrophages did not correlate significantly with the concentrations of protein carbonyls (Table 4).

Table 4 Association between protein carbonyl concentrations and BAL fluid measurements

Furthermore, the concentrations of carbonyl residues showed a significant association with concentrations of MDA in atopic asthmatic children (r = 0.61, n = 11, p = 0.044) but not in control children (r = 0.50, n = 11, p = 0.12;Fig. 5).

Figure 5
figure 5

Association between the concentration of protein carbonyls (nmol/L) and lipid peroxidation products (measured as MDAs; μmol/L) in BAL fluid of atopic, asthmatic children (□;r = 0.614, p = 0.044, n = 11) and nonasthmatic control children (▪;r = 0.50, p = 0.12, n = 11). Statistical correlations were performed using the Spearman's correlation coefficient. A p value of <0.05 was considered statistically significant.

There is concern that the concentrations of carbonyl residues may increase with the increase in total protein during inflammation. However, in atopic asthmatic children the concentration of protein carbonyls (in nmol/mg) did not correlate significantly with total protein (in mg/L;r = 0.006, p = 0.96, n = 61). Although some of the significant correlations between antioxidants (in μmol/mg protein) and carbonyls (in nmol/mg) in lavage fluid disappeared, oxidized proteins were still significantly correlated with the numbers of inflammatory cells (Table 4).

In atopic asthmatic children there was no significant correlation between the concentrations of antioxidants in BAL fluid and their serum concentration. The correlation coefficients were for ascorbate, r = −0.04, p = 0.81, n = 37; for urate, r = 0.13, p = 0.42, n = 38; and for α-tocopherol, r = −0.10, p = 0.59, n = 28).

There were no statistically significant differences found in concentrations of total protein, antioxidants, and protein carbonyls for atopic, asthmatic children taking ICS, β2-adrenergic agonists alone, or no treatment (p > 0.05 for each comparison; data not shown).

DISCUSSION

Earlier studies in adults have indicated that increased oxidative stress may occur in the circulation and airways of asthmatic subjects (1012). The epithelial lining fluid of the lung contains high concentration of antioxidants, which provide a first line of defense against inhaled, but also endogenously produced, oxidants (1, 2). A change in the antioxidant–oxidant balance in BAL fluid in children with asthma may be an indicator of ongoing inflammation even in symptom-free periods. Therefore, the aim of this study was to compare the concentrations of antioxidants and protein carbonyls in BAL fluid of atopic asthmatic children with recently published reference intervals for nonasthmatic children (16).

We found a wide range of all antioxidant concentrations in BAL fluid ranging from 0.106 to 1.985 μmol/L for ascorbate, from 0.120 to 2.498 μmol/L for urate, from 0.003 to 0.126 μmol/L for α-tocopherol, and from 0.208 to 5.011 nmol/mg for carbonyl residues in proteins, and these did not differ between stable atopic asthmatic children and the control group. Both ascorbate and urate have been shown to be powerful antioxidants in plasma (25) and BAL fluid (1, 2). In humans a decrease in BAL fluid antioxidants has been shown in response to exposure to air pollutants such as ozone (26), nitrogen dioxide (1), and small particulates (27). Moreover, in guinea pigs the induction of an allergic pulmonary response leads to increased lipid peroxidation and decreased antioxidants (α-tocopherol, ascorbate, and thiols) in BAL fluid (28). Recently, decreased concentrations of ascorbate and α-tocopherol and increased concentrations of urate have been shown after exercise in mild asthmatic adults (9, 29). The reason we did not find such a difference may be because our study group did not exercise before BAL and is much younger.

In nonasthmatic controls we have reported a weak but significant correlation between serum and BAL fluid concentrations of ascorbate, which has not been found in adults (30). As urate and ascorbate concentrations correlated strongly with protein concentrations in both groups of children, this suggests that ascorbate and urate diffuse along with protein into the epithelial lining fluid (2). However, in atopic asthmatic children we found no association between serum and BAL fluid concentrations of antioxidants. Two factors could account for this. First, in asthmatic children ascorbate in BAL fluid may have been consumed by oxidants. Second, as we did not find an overall decrease of ascorbate in BAL fluid, ascorbate might have been released from cells in the epithelial lining fluid. The problem with correction of BAL fluid measurements for a common denominator has been discussed controversially. In keeping with the recommendations of the European Respiratory Society Task Force on BAL, we present our data in concentrations per milliliter of recovered BAL fluid (31). Nevertheless, when corrected for total protein a trend toward decreased concentrations of ascorbic acid and uric acid in atopic asthmatic children was observed despite the fact that similar total protein concentrations were found in both groups, again indicating that antioxidant consumption may have been increased in the lungs of atopic asthmatic children.

We investigated the antioxidants ascorbate and urate, which are known to be among the most important water-soluble antioxidants in the epithelial lining fluid together with glutathione. Owing to their hydrophobic character they may have antioxidant function in the intra- and extracellular space. To evaluate an antioxidant–oxidant imbalance it would have been advantageous to determine the ratios between ascorbate and oxidized ascorbate (dehydroascorbate), and urate and one of its oxidation products, allantoin. However, both ascorbate and dehydroascorbate will be very rapidly oxidized. We therefore decided to reduce all ascorbate directly after sampling. Methodological difficulties in analyzing allantoin have resulted in a large number of methodological publications (3234), none of which could be applied to our BAL samples.

Additionally we investigated the concentrations of two oxidation products (protein carbonyls for oxidation of proteins and MDAs for oxidative modification of lipids). Although no significant increase in the concentrations of oxidized proteins was observed in BAL fluid, there was a trend for higher concentrations in protein carbonyls in atopic asthmatic children compared with controls. This is in agreement with Foreman et al. (35), who have shown increased numbers of protein carbonyls in BAL proteins of atopic asthmatic adults 18 h after allergen challenge. Additionally, in a small subgroup of our atopic asthmatic and control children we measured the concentrations of MDA, a marker of lipid peroxidation. Both markers of oxidative stress (protein carbonyls and MDA) correlate strongly with each other in atopic asthmatic children, suggesting that oxidative stress occurs simultaneously in both proteins and lipids.

The numbers of inflammatory cells are weakly correlated with the concentration of oxidized protein in all children (data not shown). When analyzing atopic, asthmatic and control children separately, these correlations are much stronger in atopic asthmatic children. Furthermore, in atopic asthmatic children, macrophage, eosinophil, and mast cell numbers are significantly correlated with the concentration of oxidized proteins. Interestingly, there was no significant association between these inflammatory cells and oxidatively modified proteins in control children, suggesting that these cells may not play a role in oxidative damage to proteins in noninflammatory conditions. In asthma, however, eosinophils contribute to oxidative modification of proteins after allergen challenge (35) and also during symptom-free periods. This is supported by our finding that, when applying our previously published upper 95% confidence limit of the 95th centile of our normal population (24) (≥0.86% or ≥0.039 × 105/mL) as the cutoff value for eosinophilic inflammation, protein carbonyls were significantly increased in atopic asthmatic children. Others have measured brominated or chlorinated proteins (tyrosines) as a marker of oxidative damage by eosinophils and neutrophils (36, 37). Although determination of those specific oxidation markers would identify more precisely the source of oxidative modification, in our group of atopic asthmatic children only eosinophils and mast cells were significantly increased in BAL fluid compared with control children, in line with our previous observations (17).

Surprisingly, analyzing the group of atopic asthmatic children separately according to their asthma treatment [parental report of the use of ICS (and bronchodilators when needed) or use of β2-adrenergic agonists only] revealed no differences in total protein, any of the antioxidants, or protein carbonyls between the two groups. A possible explanation could be that the distribution and absorption of inhaled drugs in the lungs of children may differ from those of adult patients. Apart from the parents' report we do not have any measure of how often and how much of the prescribed drugs have been used.

The lipid-soluble micronutrient antioxidants α-tocopherol, retinol, α- and β-carotene, and lycopene, as well as uric acid and ascorbic acid, were determined in serum. No statistical differences were found in ascorbate, urate, α-tocopherol, retinol, β-carotene, and lycopene concentrations in this study between the groups. Only one older study by Olusi et al. (38) found significantly decreased ascorbic acid in the plasma of children with asthma. More recently in children with exercise-induced bronchoconstriction, an association between resting forced expiratory volume in 1 s and serum α-tocopherol concentrations was reported in boys and between forced expiratory volume in 1 s and retinol concentrations in girls (39). Atopic asthmatic children in this study had significantly lower serum concentrations of α-carotene than controls. Carotenoids have antioxidant activity, suggesting that they might be reduced in plasma by increased oxidative stress. However, the dietary intake of fresh fruit and vegetables was not determined in this study. Although a lower intake of vitamins in atopic asthmatic children cannot be excluded, an exclusive lower intake of carotenoids is unlikely, as the serum concentrations of the other vitamins were similar between groups.

CONCLUSIONS

In summary, overall the BAL antioxidant concentrations investigated in this study did not differ between currently healthy atopic asthmatic children and control children. A previously described association between serum and BAL fluid ascorbate in nonasthmatic children was not found in asthmatic children, which may suggest a higher consumption by oxidants in some children. However, increased BAL eosinophils indicate ongoing airway inflammation, which may increase oxidatively modified proteins as reflected by increased protein carbonyl concentrations in our group of children with elevated numbers of eosinophils in BAL fluid.